603993.SS vs SUNPHARMA.NS — which is stronger right now?
Same dated snapshot (2026-09-01): 603993.SS quality —/100 vs SUNPHARMA.NS —/100; engine LONG vs LONG. The comparison below is computed, dated, and auditable — not an opinion.
| Snapshot | 2026-09-01 · source: tencent | |
|---|---|---|
| 603993.SS (Luoyang Molybdenum) | SUNPHARMA.NS (Sun Pharmaceutical) | |
| Market / sector | ashare · Metals | in · Pharma |
| Price | ¥19.52 | ₹1,913 |
| Quality score | —/100 | —/100 |
| Engine signal | LONG · 300 bars · uPnL +176.8% | LONG · 235 bars · uPnL +16.0% |
| Total return | +176.8% | +8.4% |
Thesis-break template (Metals)
core revenue contracting two quarters; margin premium eroding; net debt deteriorating; key-executive exits
Cite this page
Balance Labs Research Desk (2026-09-01). "603993.SS vs SUNPHARMA.NS — which is stronger right now?." balancelabs.app · https://balancelabs.app/stocks/compare/603993.ss-vs-sunpharma.ns · CC BY 4.0
Ask anything
Ask AI: 603993.SS vs SUNPHARMA.NS?What breaks the 603993.SS thesis?What breaks the SUNPHARMA.NS thesis?
30 free credits monthly · no card required · research support, not advice
← compare hub · snapshot 2026-09-01 · not investment advice